Insilico

Insilico Biotechnology AG is a privately held company founded in 2001 and based in Stuttgart, Germany, providing software and services for the simulation of living cells. It delivers predictive Digital Twins for the biopharmaceutical industry, combining genome-based metabolic network models, process models and AI to optimise cell lines, media, feeding strategies and bioprocess control. Its two main areas are biotechnological process optimisation services for pharmaceutical and industrial biotech companies and software engineering of proprietary simulation software and high performance computing platforms.